3 unknown, 2 completed, 1 terminated. 3 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Unknown 1 |
| Phase 3 | 3 | Unknown 2, Terminated 1 |
Follow Apixaban 5MG: new trials by email Literature Review of Apixaban 5MG trials Research Report on Apixaban 5MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence Study of Apixaban 5 mg Film-coated Tablets in Healthy Thai Volunteers Apixaban 5MG - Healthy Volunteer | Phase 1 | Unknown | International Bio service | 28 | 2024-08-26 | 2024-05-24 |
| PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers Tegoprazan 50mg, Edoxaban 60mg, Apixaban 5mg - Healthy | Phase 1 | Completed | HK inno.N Corporation | 87 | 2023-03-06 | 2023-12-11 |
| Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Healthy, Adult, Human Subjects Apixaban 5MG, Eliquis 5 mg - Antithrombic Drug | Phase 1 | Completed | Humanis Saglık Anonim Sirketi | 30 | 2023-02-23 | 2025-09-15 |
| Dabigatran Versus Apixaban in Cerebral Venous Thrombosis Dabigatran Etexilate 150mg, Apixaban 5MG - Cerebral Venous Sinus Thrombosis | Phase 3 | Unknown | Kafrelsheikh University | 200 | 2021-08-01 | 2024-08-13 |
| Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis Apixaban 5MG, Rivaroxaban 20 MG Oral Tablet - Cerebral Venous Thrombosis | Phase 3 | Unknown | Kafrelsheikh University | 200 | 2021-08-01 | 2024-08-19 |
| COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Apixaban 2.5 MG, Apixaban 5MG, Aspirin - COVID-19 | Phase 3 | Terminated | Frank C Sciurba | 657 | 2020-09-07 | 2022-02-17 |
Intracranial Thrombosis (2) · COVID-19 (1)
Kafrelsheikh University (2) · Frank C Sciurba (1) · HK inno.N Corporation (1) · Humanis Saglık Anonim Sirketi (1) · International Bio service (1)
Egypt (2) · India (1) · South Korea (1) · United States (1)
Frank Sciurba (1) · Min-Gul Kim (1) · Porranee Puranajoti, Ph. D (1)
PMID 31867054, PMID 18190818, PMID 34473343, PMID 34633405, PMID 37189091, PMID 37489818, PMID 37591523